title: Acute presentation of rheumatoid arthritis following cancer chemotherapy using the topoisomerase I inhibitor irinotecan.
authors.affiliation: Division of Haematology/Oncology, Department of Medicine, Queen Mary Hospital, University of Hong Kong, Hong Kong.
authors.forename: Thomas C
authors.initials: TC
authors.lastname: Yau
authors.forename: Kin W
authors.initials: KW
authors.lastname: Chu
authors.forename: Mo Y
authors.initials: MY
authors.lastname: Mok
authors.forename: Raymond H
authors.initials: RH
authors.lastname: Liang
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Epstein
mesh_terms: D000208:Acute Disease; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000139:chemically induced*; D002166:Camptothecin / Q000009:adverse effects / Q000031:analogs & derivatives*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000473:pathology; D006801:Humans; D000077146:Irinotecan; D008297:Male; D008875:Middle Aged; D059004:Topoisomerase I Inhibitors
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D059004:Topoisomerase I Inhibitors; D000077146:Irinotecan; D002166:Camptothecin